NEXTGENONCOLOGY LIMITED
Significant control: Syeda Sarwat Kamal (25–50%), Marcus Eli Remer (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Nextgenoncology Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Nextgenoncology Limited sell?
Registered activity: Specialists medical practice activities (SIC 86220). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
NEXTGENONCOLOGY LIMITED is an active private limited company (company number 14087498) incorporated on 5 May 2022, registered in Barkingside. Its registered activity is specialists medical practice activities (SIC 86220). Latest micro accounts cover the period ending 30 April 2026, showing net assets of £255k, with 1 employee on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 50% on the prior period (£170k). Across the last 3 periods on record the net-asset trend is rising.
By net assets it sits in the top quarter of 1,823 comparable companies in Greater London (median £18k, upper quartile £117k).
Ownership and control
- Mrs Syeda Sarwat Kamal
- owns 25–50% of shares
- holds 25–50% of voting rights
- Mr Marcus Eli Remer
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 5 May 20224 yrs ago
- Next accounts due
- 30 January 2028in 459 days
- Confirmation statement due
- 19 May 2027in 203 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 86220
- Specialists medical practice activities
- SIC 86900
- Other human health activities
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 April 2026 | £255k | — | — | £53k | — | — | 1 |
| 30 April 2025 | £170k | — | — | £64k | — | — | 1 |
| 30 April 2024 | £87k | — | — | £45k | — | — | 1 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets above zeroNet assets £255,385 at 30 April 2026
- Net assets up 10% or more on the prior period+49.9% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 5.51
- Three or more accounting periods on record3 periods on record
- Incorporated two to five years agoIncorporated 5 May 2022
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 459 days
- Confirmation statement duein 203 days
- Accounts period endNet assets £255k · micro accounts
- Accounts period endNet assets £170k · micro accounts
- Accounts period endNet assets £87k · micro accounts
- Incorporated
Similar companies in Greater London
- HARIYLA CONSULTING LIMITEDHarrow · inc. May 2022
- MUSHAHID MEDICAL LTDWatford · inc. May 2022
- SZ DERMATOLOGY LONDON LTDBeckenham · inc. May 2022
- TOP-SURGI-MEDICA LTDEnfield · inc. May 2022
- TANISHI MEDICAL SERVICES LTDPinner · inc. May 2022
- ELITE PERFORMANCE PHYSIO LIMITEDSidcup · inc. Apr 2022
All companies incorporated on 5 May 2022 · in May 2022.
Reminders for NEXTGENONCOLOGY LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.